(Q39359828)

11 September 2017

title

Luteolin reduces zinc-induced tau phosphorylation at Ser262/356 in an ROS-dependent manner in SH-SY5Y cells (English)

1 reference

11 September 2017

0 references

Futao Zhou

1

1 reference

11 September 2017

Shuangrong Chen

2

1 reference

11 September 2017

Jinping Xiong

3

1 reference

11 September 2017

Yinghui Li

4

1 reference

11 September 2017

Lina Qu

5

1 reference

11 September 2017

publication date

14 April 2012

1 reference

Biological Trace Element Research

11 September 2017

published in

1 reference

11 September 2017

volume

149

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

273-279

1 reference

https://scigraph.springernature.com/pub.10.1007/s12011-012-9411-z

11 September 2017

exact match

0 references

cites work

Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Elevated cortical zinc in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Enhanced zinc consumption causes memory deficits and increased brain levels of zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease beta-amyloid production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Luteolin protects against reactive oxygen species-mediated cell death induced by zinc toxicity via the PI3K-Akt-NF-κB-ERK-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

GPx-1 gene delivery modulates NFkappaB activation following diverse environmental injuries through a specific subunit of the IKK complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Acute hypoxia promote the phosphorylation of tau via ERK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: the role of AKT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

The role of tau in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Mechanisms of tau-induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A- and glycogen synthase kinase-3 -dependent phosphorylation of Tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Ser-262 in human recombinant tau protein is a markedly more favorable site for phosphorylation by CaMKII than PKA or PhK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Ribosome dysfunction is an early event in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Parallel increase in p70 kinase activation and tau phosphorylation (S262) with Abeta overproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Increased tau phosphorylation on mitogen-activated protein kinase consensus sites and cognitive decline in transgenic models for Alzheimer's disease and FTDP-17: evidence for distinct molecular processes underlying tau abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Mitochondrial oxidative stress causes hyperphosphorylation of tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Oxidative stress promotes tau dephosphorylation in neuronal cells: the roles of cdk5 and PP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Selenium modulates oxidative stress-induced cell apoptosis in human myeloid HL-60 cells through regulation of calcium release and caspase-3 and -9 activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

Tau dephosphorylation potentiates apoptosis by mechanisms involving a failed dephosphorylation/activation of Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-012-9411-Z

10.1007/S12011-012-9411-Z

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference